Dec 01, 2021 / 01:50PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD
Okay. Good morning, everyone. Thanks for joining us on day 2 of the HealthCONx. We're kicking off the life science tools at the Avantor. And we have CEO, Michael Stubblefield; and CFO, Tom Szlosek; and I think Tommy Thomas, who heads Investor Relations, in the background. Michael, Tom, thank you for taking the time this morning.
Michael Stubblefield - Avantor, Inc. - President, CEO & Director
Vijay, great to see you. I appreciate you hosting us today.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MDAnd it's -- for you guys, Michael, it's been a really interesting 3 months for it. I just -- like that Analyst Day was -- that there were so many bullish data points in that Analyst Day. And then we went through a month, 2 months of confusion. And I think the 3Q earnings cleared a lot of the confusion around debt financing and what was said or not said.